President & CEO of Salix Pharmaceuticals Ltd. (SLXP, Financial) Carolyn J Logan sells 14,000 shares of SLXP on 09/21/2010 at an average price of $42.35 a share.
Salix Pharmaceuticals Ltd. has a market cap of $2.45 billion; its shares were traded at around $42.4 with and P/S ratio of 10.5.
SLXP is in the portfolios of Louis Moore Bacon of Moore Capital Management, LP, Steven Cohen of SAC Capital Advisors, RS Investment Management.
Salix Pharmaceuticals Ltd. has a market cap of $2.45 billion; its shares were traded at around $42.4 with and P/S ratio of 10.5.
SLXP is in the portfolios of Louis Moore Bacon of Moore Capital Management, LP, Steven Cohen of SAC Capital Advisors, RS Investment Management.
Directors and Officers Recent Trades:
- Sell: V.P. Research& Devel & CDO William P Forbes sold 10,695 shares of SLXP stock on 09/15/2010 at the average price of 40.5. William P Forbes owns at least 57,657 shares after this. The price of the stock has increased by 4.69% since.
- Sell: Director John F Chappell sold 4,676 shares of SLXP stock on 09/09/2010 at the average price of 40.92. John F Chappell owns at least 710,804 shares after this. The price of the stock has increased by 3.62% since.
- Sell: Director John F Chappell sold 4,000 shares of SLXP stock on 09/07/2010 at the average price of 40.42. John F Chappell owns at least 715,480 shares after this. The price of the stock has increased by 4.9% since.
- Sell: Director Richard A Franco sold 6,500 shares of SLXP stock on 09/03/2010 at the average price of 40. Richard A Franco owns at least 41,334 shares after this. The price of the stock has increased by 6% since.
- Sell: Director John F Chappell sold 4,000 shares of SLXP stock on 09/02/2010 at the average price of 39.4. John F Chappell owns at least 719,480 shares after this. The price of the stock has increased by 7.61% since.
